Costanza joined Hanson Wade in 2021 after completion of her MScR in Biomedical Sciences at the University of Edinburgh. She is the Beacon Targeted Therapies resident analyst expert on the Microbiome module and frequently reviews key trends in the live biotherapeutic, bacteriophage and microbiome-sourced molecules drug areas such as species, therapy types, disease indications, drug discontinuation, and more. Costanza has also published digests, landscape reviews, infographics and presented at conferences pertaining to the microbiome drug development space.